1. LBA18Survival and treatment patterns in patients (pts) with locally advanced or metastatic NSCLC treated with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIS): Analysis of US insurance claims databases. (24th November 2019) Authors: Soo, R; Seto, T; Gray, J E; Karimi, P; Taylor, A; Sawyer, W; Thiel, E; Marchlewicz, E; Brouillette, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗